Charles Schwab Investment Management Inc. Cuts Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...
10x Genomics: Lower Cost Innovation May Drive A Rebound
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
Investor's Business Daily on MSN5mon
10x Genomics Crashes After 'Disruptive' Reorg Upsets Third-Quarter Sales
"We believe it could take time for 10x to properly orient its Chromium commercial efforts." He has a buy rating on 10x ...
Yahoo Finance1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to ... giving researchers full control and flexibility over how they design and scale their studies.
Saint Louis University2mon
Genomics Core Facility
The Genomics Core houses a 10X Genomics Chromium iX which has the capacity to prepare GEMs for all standard 10X Genomics single cell pipelines: 3" scRNAseq single cell immune profiling fixed RNA ...
Seeking Alpha6d
TXG 10x Genomics, Inc.
10x Genomics, Inc., a life science technology ... and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic ...
Stockhouse1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance ... giving researchers full control and flexibility over how they design and ...